Yes. Found Health (joinfound.com) is a legitimate GLP-1 telehealth platform. Found uses US-licensed clinicians, FDA-regulated 503A sterile compounding pharmacies, and complies with state telehealth prescribing laws. The semaglutide and tirzepatide they prescribe use the same active pharmaceutical molecules as Wegovy, Ozempic, Zepbound, and Mounjaro. Found is not a scam.
The honest follow-up: Found has genuine limitations worth understanding before enrolling — primarily around pharmacy transparency, promotional first-month pricing that increases significantly after month one, and dose-tier pricing at maintenance. These are service model limitations, not legitimacy concerns.
The Legitimacy Checklist: What Makes a GLP-1 Telehealth Platform Safe
Before evaluating Found specifically, it helps to know what criteria actually determine whether a GLP-1 telehealth provider is legitimate and safe.
What "Illegitimate" Actually Looks Like — And Why Found Isn't That
Red Flags of Illegitimate GLP-1 Providers
Found's Genuine Limitations — What You Should Know
Legitimacy and optimal value are different questions. Found is legitimate; the following are service model limitations that matter for an informed decision, not safety concerns.
Promotional first-month pricing
Found frequently advertises a promotional first-month rate (~$99) that is significantly lower than their ongoing subscription rate (~$169–$269/month depending on plan and dose tier). Verify the ongoing monthly rate — not the promotional rate — before enrolling.
Compounding pharmacy not publicly named
Found does not prominently disclose which specific pharmacy prepares their GLP-1 medications. Contact Found support and ask for the pharmacy's name and state board license number.
Dose-tier pricing at maintenance
Found's pricing is dose-dependent — monthly cost increases as your dose increases through titration. Understand the full pricing structure across the typical titration timeline before committing.
Found vs Luma Health: Verified Comparison
| Factor | Found Health | Luma Health |
|---|---|---|
| Pricing structure | ~$99 promo → $169–$269/mo ongoing | $197/mo flat — no promo that resets |
| Coaching | ✓ Included | Not included |
| Tirzepatide | ✓ ~$199–$249/mo | ✓ $297/mo flat |
| Pharmacy named publicly | Not prominently | ✓ VialsRX TX#35264 |
| 50-state availability | ✓ All 50 states | ✓ All 50 states |
Pharmacy named.
Pricing that doesn't hike.
$197/mo flat. VialsRX (TX #35264). No contracts.
Start With Luma Health →Frequently Asked Questions
No. Found Health is a legitimate GLP-1 telehealth platform. They use US-licensed clinicians, FDA-regulated 503A compounding pharmacies, and comply with state telehealth laws. Patient complaints about Found typically address service model issues — pricing structure and pharmacy transparency — not safety or legitimacy.
Found is not itself FDA-approved — no telehealth platform receives FDA approval as a platform. What matters is that Found's licensed clinicians prescribe medications with FDA-approved active ingredients, prepared by licensed 503A pharmacies regulated by state pharmacy boards.
Found offers promotional first-month pricing (~$99) to reduce enrollment friction. The ongoing rate from month two forward is significantly higher (~$169–$269/month). Confirm the exact ongoing rate before enrolling.
Yes. Found uses FDA-regulated 503A sterile compounding pharmacies. Found does not publicly name its specific pharmacy partner(s) — contact support and ask for the name and license number if you want to verify independently.
Five things: (1) a licensed clinician conducts your evaluation, (2) the compounding pharmacy's name and license number, (3) the ongoing monthly rate after any promotional period, (4) the cancellation policy, and (5) that the provider is licensed in your state. These apply to any GLP-1 telehealth platform.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- FDA. BeSafeRx — Online Pharmacy Verification. FDA.gov
- Found Health. Official Website. joinfound.com
- Texas State Board of Pharmacy. License Verification. pharmacy.texas.gov
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov